合肥市未来药物开发有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
19
NMPA:19
Drug Approvals
Multi-Trace Elements Injection（I）
- Product Name
- 多种微量元素注射液(Ⅰ)
- Approval Number
- 国药准字H20253964
- Approval Date
- Apr 22, 2025
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20244330
- Approval Date
- Jun 28, 2024
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20244329
- Approval Date
- Jun 28, 2024
NMPA
Dopamine Hydrochloride Injection
- Product Name
- 盐酸多巴胺注射液
- Approval Number
- 国药准字H20244331
- Approval Date
- Jun 28, 2024
NMPA
Atomoxetine Hydrochloride Oral Solution
- Product Name
- 盐酸托莫西汀口服溶液
- Approval Number
- 国药准字H20234229
- Approval Date
- Sep 28, 2023
NMPA
Fludrocortisone Acetate Tablets
- Product Name
- 醋酸氟氢可的松片
- Approval Number
- 国药准字H20234082
- Approval Date
- Aug 29, 2023
NMPA
Dopamine hydrochloride for Injection
- Product Name
- 注射用盐酸多巴胺
- Approval Number
- 国药准字H20041357
- Approval Date
- Jul 3, 2020
NMPA
- Prev
- 1
- 2
- Next
Clinical Trials
No trials found
News
No news found